Part of a four-part webinar series from the American Society of Nuclear Cardiology (ASNC) and the British Nuclear Medicine Society (BNMS), exploring key topics in nuclear cardiology and chaired by junior and senior nuclear cardiologists.
This opening session looks at myocardial blood flow quantification: when and why it matters, cases where it changes the answer, and the challenges and advantages of imaging with 18F-flurpiridaz. Each webinar is one hour: three talks, then a 15-minute panel discussion and Q&A.
- Dr George CollinsBarts Health NHS Trust, UK
- Dr Kshama WechalekarRoyal Brompton and Harefield Hospitals, UK
- When and Why Myocardial Blood Flow Quantification MattersDr Ranil DeSilva, Royal Brompton and Harefield Hospitals, UK
- Cases Where Quantification MattersDr Parthi Arumugam, Manchester University Hospital, UK
- Imaging with 18F-Flurpiridaz – Challenges and AdvantagesDr Mouaz Al-Mallah, Houston Methodist Hospital DeBakey Heart & Vascular Center, USA
- Panel discussion and Q&A15 minutes
- 13 Oct 2026 – Myocardial Perfusion Imaging (this session)
- 15 Dec 2026 – Cardiac Amyloidosis
- 9 Mar 2027 – Cardiac Sarcoidosis
- 20 Apr 2027 – Infective Endocarditis
Registration for this session will open on the BNMS website; the button goes to the BNMS events calendar until then. All four webinars are free to attend and run 6–7 PM UK (1–2 PM US Eastern). Registration is handled by the British Nuclear Medicine Society.